Duncan, Kenneth W.,Chesworth, Richard,Boriack-Sjodin, Paula Ann,Munchhof, Michael John,Jin, Lei
申请号：
AU2013364033
公开号：
AU2013364033A1
申请日:
2013.12.20
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5- mediated disorders are also described.
